Butyrolactone I
Butyrolactone I (Olomoucin) is a potent, ATP-competitive inhibitor of CDK and cdc2 kinase families. It has demonstrated antitumor activity in vitro against various cancer cell lines, including non-small cell lung, small cell lung, and prostate cancers, making it a valuable tool for cell cycle and oncology research.
Product Specifications
CAS Number
87414-49-1
Product Name Alternative
CDK2, Cdc2/CyclinB, Butyrolactone I, Olomoucin
Field of Research
Cell Biology, Immunology & Inflammation, Signal Transduction
Purity
98.00% (May vary between batches)
Solubility
DMSO:80 mg/mL (188.48 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.77 mM)
Smiles
COC (=O) [C@]1 (Cc2ccc (O) c (CC=C (C) C) c2) OC (=O) C (O) =C1c1ccc (O) cc1
Molecular Formula
C24H24O7
Molecular Weight
424.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
032037-ML490 100 µL
ARHGAP17, NT (ARHGAP17, RICH1, Rho GTPase-activating protein 17, Rho-type GTPase-activating protein 17, RhoGAP interacting with CIP4 homologs protein 1) (MaxLight 490) discontinued
Sign In for Pricing
View Details K4981707 1.0 µg DNA
Vsnl1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details